Department of Pharmacology, Hamamatsu University School of Medicine, 1-20-1 Handayama, Hamamatsu, Shizuoka, 431-3192, Japan.
Cytotechnology. 2013 Mar;65(2):173-8. doi: 10.1007/s10616-012-9473-y. Epub 2012 Jun 16.
The Drosophila melanogaster Schneider 2 (S2) cell line was established in 1972. Many studies have indicated that generation of recombinant proteins with S2 cells is more desirable than using other methods, since native proteins derived from S2 cells do not usually interact with those derived from mammalian cells. In order to minimize the duration for selections, we established an all-in-one single plasmid pMT-PURO, which enables to express the gene of interest as well as a selection gene "pac". However, there is a weak point in the system. In order to verify the hallmark of the transformed cells, puromycin selection as well as verification of the gene of interests is still necessary. To improve this situation, we generated pMT-PURO2G and pMT-PURO2R, which enable to verify the hallmark of the transformed cells during the selections by the detection of enhanced green fluorescent protein (EGFP) or DsRED2. This new system gives reliable and reproductive results for recombinant protein synthesis and gets rid of some degree of uncertainty for the outcome of the transfection.
黑腹果蝇 Schneider 2(S2)细胞系于 1972 年建立。许多研究表明,使用 S2 细胞生成重组蛋白比使用其他方法更可取,因为源自 S2 细胞的天然蛋白通常不会与源自哺乳动物细胞的蛋白相互作用。为了最大限度地缩短选择时间,我们建立了一个全合一的单质粒 pMT-PURO,它可以表达目的基因和一个选择基因“pac”。然而,该系统存在一个弱点。为了验证转化细胞的特征,仍然需要进行嘌呤霉素选择以及目的基因的验证。为了改善这种情况,我们生成了 pMT-PURO2G 和 pMT-PURO2R,它们可以通过检测增强型绿色荧光蛋白(EGFP)或 DsRED2 在选择过程中验证转化细胞的特征。这个新系统为重组蛋白的合成提供了可靠和可重复的结果,并在一定程度上消除了转染结果的不确定性。